Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2000
11/02/2000EP1047769A1 Novel therapeutic uses of heterologous superoxide dismutase (hsd), and method for selecting said hsd
11/02/2000EP1047714A1 HUMAN CMRF-35-H9 RECEPTOR WHICH BINDS IgM
11/02/2000EP1047713A1 Secreted proteins and polynucleotides encoding them
11/02/2000EP1047711A1 Nucleic acid sequences encoding capsaicin receptors
11/02/2000EP1047709A1 Compounds with growth hormone releasing properties
11/02/2000EP1047708A1 Peptide chelators that predominately form a single stereoisomeric species upon coordination to a metal center
11/02/2000EP1047707A1 Isolated, polypeptides which bind to hla-a29 molecules, nucleic acid, the molecules encoding these, and uses thereof
11/02/2000EP1047456A1 A method and composition for cancer treatment by enzymatic conversion of soluble radioactive toxic agents
11/02/2000EP1047452A1 Conjugates comprising two active agents
11/02/2000EP1047451A1 Use of heat shock proteins to deliver moieties into cells
11/02/2000EP1047450A1 Ace inhibitor-mmp inhibitor combinations
11/02/2000EP1047449A1 Immunological compositions and methods of use to transiently alter mammalian central nervous system myelin to promote neuronal regeneration
11/02/2000EP1047444A1 Methods of neuroendocrine regulation of affective disorders
11/02/2000EP1047443A1 Methods and compositions for enhancing cognitive function using morphogenic proteins
11/02/2000EP1047442A1 Bone morphogenetic proteins and their use in bone growth
11/02/2000EP1047441A1 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
11/02/2000EP1047437A1 Sea cucumber carotenoid lipid fraction products and methods of use
11/02/2000EP1047422A1 Use of histamine for elevating blood histamine levels
11/02/2000EP1047398A1 Topical compositions containing whey proteins
11/02/2000EP1047301A1 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (prrsv)
11/02/2000EP0914331B1 Neuroactive peptides
11/02/2000EP0853485A4 Therapeutic administration of hemoglobin in cardiac arrest
11/02/2000EP0822991A4 Methods, polypeptides, nucleotide sequence of xor-6, a vitamin d-like receptor from xenopus
11/02/2000EP0812207B1 Morphogen-induced dentine regeneration
11/02/2000EP0790059A4 Means for treating auto-immune diseases and method of treatment
11/02/2000EP0662148B1 Monoclonal antibodies reactive with defined regions of the t cell antigen receptor
11/02/2000DE19917990A1 Arzneimittel enthaltend Hemmstoffe der zellvolumenregulierten humanen Kinase h-sgk Medicines containing inhibitors of cell volume-regulated human kinase h-sgk
11/02/2000CA2371662A1 Peptide homodimers and peptide heterodimers, derived from interferon .alpha.2
11/02/2000CA2371241A1 Tgf-.alpha. polypeptides, functional fragments and methods of use therefor
11/02/2000CA2371217A1 A pharmaceutical formulation containing an inhibitor of carboxypeptidase u and a thrombin inhibitor
11/02/2000CA2371114A1 Death domain containing receptors
11/02/2000CA2371064A1 Methods of delivery of cetyl myristoleate
11/02/2000CA2371046A1 Therapeutic compositions and methods for enhancing angiogenesis
11/02/2000CA2371008A1 A pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug
11/02/2000CA2370404A1 Use of a recombinant defective adenovirus comprising a nucleic acid encoding an angiogenic factor for treating pulmonary hypertension
11/02/2000CA2370306A1 Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains
11/02/2000CA2370302A1 Insulin crystals for pulmonary administration
11/02/2000CA2370298A1 Peptide homodimers or peptide heterodimers derived from interleukin 12
11/02/2000CA2370292A1 Transcriptional activation inhibitory protein
11/02/2000CA2370286A1 A ligand of the protein "beacon"
11/02/2000CA2370284A1 Membrane disruptive peptides covalently oligomerized
11/02/2000CA2370195A1 Human membrane-associated proteins
11/02/2000CA2369910A1 Compositions and methods for treatment of hyperproliferative diseases
11/02/2000CA2369579A1 Controlled release of growth factors from heparin containing matrices
11/02/2000CA2369324A1 G-protein coupled receptor and method of using same
11/02/2000CA2368793A1 Releasable linkage and compositions containing same
11/02/2000CA2368213A1 Specifically targeted catalytic antagonists and uses thereof
11/02/2000CA2368205A1 N-protected amines and their use as prodrugs
11/02/2000CA2367965A1 Human gil-19/ae289 proteins and polynucleotides encoding same
11/02/2000CA2367830A1 Method of inhibiting leukocyte adhesion to fibrinogen
11/02/2000CA2367750A1 Tribonectins
11/01/2000CN1272139A Nucleic acids coding for proteins capable of interacting with presenilins
11/01/2000CN1272118A Collagen type I and type III adhesive compositions
11/01/2000CN1272115A Human VAMP-2 like gene (CBCBMH06)
11/01/2000CN1272114A Phenethylamine derivatives
11/01/2000CN1272043A Nutritional composition for treatment of pressure ulcers
11/01/2000CN1271608A Health-care enzymatic chitosan food
11/01/2000CN1058021C New peptides derived from trifluorumethylketones, process for their preparation and pharmaceutical compositions which contain them
11/01/2000CN1058020C Angiotensin converting enzyme inhibitor and method for preparing same
11/01/2000CN1058019C 环状氨基酸衍生物 Cyclic amino acid derivatives
11/01/2000CN1058013C Process for preparation of novel mercaptoacetylamide derivatives
11/01/2000CN1057937C Use of lysozyme dimer and preparations containing same
10/2000
10/31/2000US6140505 Synthesis of benzo fused heterocyclic sulfonyl chlorides
10/31/2000US6140492 Antisense transcript expressed in B lymphocytes and synthetic oligonucleotides useful to inhibit the activity thereof
10/31/2000US6140491 Enzymatic nucleic acid which cleaves ribonucleic acids; has hammerhead motif and has at least one sugar-sugar backbone linkage which is different from a phosphodiester linkage; more stable than ribozymes; antisense agents; viricides
10/31/2000US6140490 Pure and non-naturally occurring rna specific rna sequence and capable of binding to c1q; identified through selex method; for drugs which suppress and activate the complement system and for diagnostic agents
10/31/2000US6140488 Ras-binding protein (PRE1)
10/31/2000US6140487 DNA encoding kojibiose phosphorylase obtainable from thermoanaerobium, ' its preparation and uses
10/31/2000US6140484 Bax ω protein and methods
10/31/2000US6140483 Human polyhomeotic 2 (hph2) acts as a tumor suppressor
10/31/2000US6140474 Monoclonal antibody reactive with human-origin CETP and method of quantifying human-origin CETP
10/31/2000US6140472 Use of chimeric vaccinia virus complement control proteins to inhibit complement
10/31/2000US6140467 Ligand for herpes simplex virus entry mediator and methods of use
10/31/2000US6140466 Comprises at least three zinc finger domains that bind to target cellular nucleotide sequence and modulate its transcription; genome-specific transcriptional switches in gene therapy; transgenic plants and animals
10/31/2000US6140465 Bau, a BIN1 interacting protein, and uses therefor
10/31/2000US6140464 Nonapeptides that bind a HLA-A2.1 molecule
10/31/2000US6140364 Arachidonic acid metabolite, 16-HETE
10/31/2000US6140357 Small molecule inhibitors of rotamase enzyme activity
10/31/2000US6140315 Administering to a human or an animal an amount of goserelin acetate sufficient to decrease atherosclerosis and its complications
10/31/2000US6140309 Inhibiting the vasoactive effects of beta-amyloid peptides by exposing vessel to a modifier of superoxide formation prior to exposure of the vessel to a amyloid peptide
10/31/2000US6140306 Concurrently administering to a patient a (bpi)bactericidal/permeability-increasing protein and a tetracyline antibiotic in the treatment of a patient infected with escherichia gram-negative bacterial species
10/31/2000US6140305 Hereditary hemochromatosis gene products
10/31/2000US6140126 Oligonucleotides which target untranslated regions coding a transcription factor; for treatment of cancer and inflamamation; anticarcinogenic agents; antiinflammatory agents
10/31/2000US6140125 Antisense inhibition of bcl-6 expression
10/31/2000US6140124 Nucleotide sequences which target untranslated regions, translation start site and translation termination position; for diagnosis and treatment of tumors, inflammation and arthritis; antitumor agents; inflammatory agents
10/31/2000US6140120 Regulated transcription of targeted genes and other biological events
10/31/2000US6140117 Ninjurin
10/31/2000US6140116 Adjusted swine neuronal cells for the treatment of humans with stroke, brain trauma, amyotrophic lateral sclerosis, multiple sclerosis, huntington's and alzheimer's disease
10/31/2000US6140114 Defective viral vaccine particles obtained in vivo or ex vivo
10/31/2000US6140113 Nucleotide sequences which codes an immunoglobulin fusion protein; for the detection and treatment of allergies, autoimmune diseases, tumors, infections, and transplant ejection; antitumor agents
10/31/2000US6140112 Pharmaceutical compositions and their use, namely for the treatment of neurodegenerative diseases
10/31/2000US6140111 Nucleotide sequences utilized for the treatment of genetic disorders in human and animal somatic cells
10/31/2000US6140101 Nucleotide sequences coding a protein with enzymatic activity; for the treatment of tumors; antitumor agents
10/31/2000US6140100 Cell-targeting molecule comprising a mutant human carboxypeptidase A
10/31/2000US6140093 Nucleotide sequences coding an enzymatic protein for use as an antidote in organophorphous insecticide poisoning and to prevent neuronal cell
10/31/2000US6140086 Methods and compositions for cloning nucleic acid molecules
10/31/2000US6140081 Nucleotide binding polypeptide; for efficient use as diagnostic tools in gene therapy and transgenic cells
10/31/2000US6140079 Nucleotide sequence coding staphylococcal protein; for the prevention of bacterial infection and development of bactericides
10/31/2000US6140073 Useful in the promotion of tissue repair
10/31/2000US6140071 Proteins with mutations to decrease N-terminal methylation
1 ... 2330 2331 2332 2333 2334 2335 2336 2337 2338 2339 2340 2341 2342 2343 2344 2345 2346 2347 2348 2349 2350 ... 3163